pubmed-article:17122430 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17122430 | lifeskim:mentions | umls-concept:C0032143 | lld:lifeskim |
pubmed-article:17122430 | lifeskim:mentions | umls-concept:C0948008 | lld:lifeskim |
pubmed-article:17122430 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
pubmed-article:17122430 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
pubmed-article:17122430 | lifeskim:mentions | umls-concept:C0520997 | lld:lifeskim |
pubmed-article:17122430 | lifeskim:mentions | umls-concept:C0010181 | lld:lifeskim |
pubmed-article:17122430 | lifeskim:mentions | umls-concept:C0557702 | lld:lifeskim |
pubmed-article:17122430 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:17122430 | pubmed:dateCreated | 2006-12-25 | lld:pubmed |
pubmed-article:17122430 | pubmed:abstractText | The aim of this study was to assess the costs and cost-effectiveness of intravenous thrombolysis treatment with alteplase (Actilyse) of acute ischemic stroke with 24-hour in-house neurology coverage and use of magnetic resonance imaging. | lld:pubmed |
pubmed-article:17122430 | pubmed:language | eng | lld:pubmed |
pubmed-article:17122430 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17122430 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17122430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17122430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17122430 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17122430 | pubmed:month | Jan | lld:pubmed |
pubmed-article:17122430 | pubmed:issn | 1524-4628 | lld:pubmed |
pubmed-article:17122430 | pubmed:author | pubmed-author:AndersenGreth... | lld:pubmed |
pubmed-article:17122430 | pubmed:author | pubmed-author:EhlersLarsL | lld:pubmed |
pubmed-article:17122430 | pubmed:author | pubmed-author:KjølbyMetteM | lld:pubmed |
pubmed-article:17122430 | pubmed:author | pubmed-author:ClausenLone... | lld:pubmed |
pubmed-article:17122430 | pubmed:author | pubmed-author:BechMereteM | lld:pubmed |
pubmed-article:17122430 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:17122430 | pubmed:volume | 38 | lld:pubmed |
pubmed-article:17122430 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17122430 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17122430 | pubmed:pagination | 85-9 | lld:pubmed |
pubmed-article:17122430 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:meshHeading | pubmed-meshheading:17122430... | lld:pubmed |
pubmed-article:17122430 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17122430 | pubmed:articleTitle | Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke. | lld:pubmed |
pubmed-article:17122430 | pubmed:affiliation | HTA Unit, Aarhus University Hospital, Olof Palmes Allé 17, 8200 Aarhus N, Denmark. le@ag.aaa.dk | lld:pubmed |
pubmed-article:17122430 | pubmed:publicationType | Journal Article | lld:pubmed |